GGrantIndex
← Search

PHASE II CLINICAL TRIALS OF NEW CHEMOPREVENTIVE AGENTS

$0N01FY2000CNNIH

St. Luke'S Roosevelt Hosp Ctr (New York), New York NY

Investigators

Abstract

The work to be provided under this project is to circumvent barriers to primary prevention and secondary prevention that Blacks face for specific cancer sites. Specifically to: 1) Identify key factors that contribute to avoidable mortality, 2) implement interventions; and 3) identify prototype approaches to the reduction of avoidable mortality for wide-spread dissemination.

View original record on NIH RePORTER →